Compare uniQure N.V. Ordinary Shares (QURE) vs Charles Schwab Corporation Common Stock (SCHW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Charles Schwab Corporation Common Stock — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B), while Charles Schwab Corporation Common Stock trades at $96.98 (market cap $167.40B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 115.4× uniQure N.V. Ordinary Shares's market cap, and Charles Schwab Corporation Common Stock pays a 1.32% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Charles Schwab Corporation Common Stock for 86 Days on average.
| QURE | SCHW | |
|---|---|---|
Market Cap | $1.45B | $167.40B |
Volume | 3,323,243 | 13,127,509 |
Sector | Health | Financials |
52-Week High | $70.59 | $113.65 |
52-Week Low | $9.03 | $85.35 |
Typical Hold Time | 0 Days | 86 Days |
Enterprise Value | $707.46M | $152.90B |
Dividend Yield | — | 1.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Charles Schwab (SCHW) trades at $95.94, down 1.15% on the day. The stock exhibits bearish technical signals with key support at $96 and resistance at $98. Fundamentally, the company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.62 surpassing the $1.56 estimate. Revenue for 2025 reached $23.92 billion, and net income margin improved to 38.79%. Recent developments include a secondary listing on the Texas Stock Exchange and a partnership with Anthropic to integrate AI tools for financial advisors.
The outlook for SCHW is positive, supported by robust earnings momentum, a favorable analyst consensus with a $120.69 price target, and growth in the e-brokerage market. Key risks include competitive pressures, interest rate sensitivity affecting net interest income, and market volatility impacting client assets. The stock presents a compelling opportunity for investors seeking exposure to a leading financial services firm with strong profitability and strategic initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →
